| Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia D Gaudet, VJ Alexander, BF Baker, D Brisson, K Tremblay, W Singleton, ... New England Journal of Medicine 373 (5), 438-447, 2015 | 548 | 2015 |
| Targeting APOC3 in the familial chylomicronemia syndrome D Gaudet, D Brisson, K Tremblay, VJ Alexander, W Singleton, SG Hughes, ... New England Journal of Medicine 371 (23), 2200-2206, 2014 | 477 | 2014 |
| Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial D Gaudet, J Méthot, S Déry, D Brisson, C Essiembre, G Tremblay, ... Gene therapy 20 (4), 361-369, 2013 | 461 | 2013 |
| Review of the clinical development of alipogene tiparvovec gene therapy for lipoprotein lipase deficiency D Gaudet, J de Wal, K Tremblay, S Déry, S van Deventer, A Freidig, ... Atherosclerosis Supplements 11 (1), 55-60, 2010 | 148 | 2010 |
| Long-term retrospective analysis of gene therapy with alipogene tiparvovec and its effect on lipoprotein lipase deficiency-induced pancreatitis D Gaudet, ES Stroes, J Methot, D Brisson, K Tremblay, SJ Bernelot Moens, ... Human gene therapy 27 (11), 916-925, 2016 | 106 | 2016 |
| Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome CD Meyers, K Tremblay, A Amer, J Chen, L Jiang, D Gaudet Lipids in health and disease 14, 1-9, 2015 | 101 | 2015 |
| Replication of an association between 17q21 SNPs and asthma in a French-Canadian familial collection AM Madore, K Tremblay, TJ Hudson, C Laprise Human genetics 123, 93-95, 2008 | 98 | 2008 |
| Etiology and risk of lactescent plasma and severe hypertriglyceridemia K Tremblay, J Méthot, D Brisson, D Gaudet Journal of clinical lipidology 5 (1), 37-44, 2011 | 72 | 2011 |
| Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients MP Frigon, MÈ Blackburn, C Dubois-Bouchard, AL Gagnon, S Tardif, ... Pharmacogenomics 20 (8), 589-598, 2019 | 68 | 2019 |
| Association of urokinase-type plasminogen activator with asthma and atopy P Bégin, K Tremblay, D Daley, M Lemire, S Claveau, C Salesse, S Kacel, ... American journal of respiratory and critical care medicine 175 (11), 1109-1116, 2007 | 64 | 2007 |
| Association study between the CX3CR1 gene and asthma K Tremblay, M Lemire, V Provost, T Pastinen, Y Renaud, AJ Sandford, ... Genes & Immunity 7 (8), 632-639, 2006 | 62 | 2006 |
| Genes to diseases (G2D) computational method to identify asthma candidate genes K Tremblay, M Lemire, C Potvin, A Tremblay, GM Hunninghake, BA Raby, ... PLoS One 3 (8), e2907, 2008 | 45 | 2008 |
| The Biobanque québécoise de la COVID-19 (BQC19)—A cohort to prospectively study the clinical and biological determinants of COVID-19 clinical trajectories K Tremblay, S Rousseau, MH Zawati, D Auld, M Chassé, D Coderre, ... PloS one 16 (5), e0245031, 2021 | 35 | 2021 |
| The DGAT1 inhibitor LCQ908 decreases triglyceride levels in patients with the familial chylomicronemia syndrome C Meyers, D Gaudet, K Tremblay, A Amer, J Chen, F Aimin Journal of Clinical Lipidology 6 (3), 266-267, 2012 | 34 | 2012 |
| Large-scale deletions of the ABCA1 gene in patients with hypoalphalipoproteinemia JS Dron, J Wang, AJ Berberich, MA Iacocca, H Cao, P Yang, J Knoll, ... Journal of Lipid Research 59 (8), 1529-1535, 2018 | 31 | 2018 |
| A comparison of two sets of microarray experiments to define allergic asthma expression pattern A Chamberland, AM Madore, K Tremblay, M Laviolette, C Laprise Experimental lung research 35 (5), 399-410, 2009 | 29 | 2009 |
| A network-informed analysis of SARS-CoV-2 and hemophagocytic lymphohistiocytosis genes’ interactions points to Neutrophil extracellular traps as mediators of thrombosis in COVID-19 J Ding, DE Hostallero, MR El Khili, GJ Fonseca, S Milette, N Noorah, ... PLoS Computational Biology 17 (3), e1008810, 2021 | 24 | 2021 |
| Comparison of the efficacy of fibrates on hypertriglyceridemic phenotypes with different genetic and clinical characteristics D Brisson, J Méthot, K Tremblay, M Tremblay, P Perron, D Gaudet Pharmacogenetics and genomics 20 (12), 742-747, 2010 | 24 | 2010 |
| Medical resource use and costs associated with chylomicronemia D Gaudet, J Signorovitch, E Swallow, L Fan, K Tremblay, D Brisson, ... Journal of medical economics 16 (5), 657-666, 2013 | 22 | 2013 |
| Genetic variation in immune signaling genes differentially expressed in asthmatic lung tissues K Tremblay, D Daley, A Chamberland, M Lemire, A Montpetit, M Laviolette, ... Journal of allergy and clinical immunology 122 (3), 529-536. e17, 2008 | 21 | 2008 |
